Myocardial Fibrosis: Why Image, How to Image and Clinical Implications

Overview

Journal Heart

Date 2019 Oct 26

PMID 31649047

Citations 46

Authors

Rong Bing

Marc Richard Dweck

Affiliations

Soon will be listed here.

Citing Articles

Diagnosis and Management of Hypertensive Heart Disease: Incorporating 2023 European Society of Hypertension and 2024 European Society of Cardiology Guideline Updates.

Wang B J Cardiovasc Dev Dis. 2025; 12(2).

PMID: 39997480 PMC: 11856785. DOI: 10.3390/jcdd12020046.

Impact of cardiovascular magnetic resonance in single ventricle physiology: a narrative review.

Voges I, Gabbert D, Panakova D, Krupickova S Cardiovasc Diagn Ther. 2025; 14(6):1161-1175.

PMID: 39790200 PMC: 11707479. DOI: 10.21037/cdt-24-409.

Myocardial Fibroblast Activation After Acute Myocardial Infarction: A Positron Emission Tomography and Magnetic Resonance Study.

Barton A, Craig N, Loganath K, Joshi S, Tsampasian V, Mahendran M J Am Coll Cardiol. 2025; 85(6):578-591.

PMID: 39772364 PMC: 11835506. DOI: 10.1016/j.jacc.2024.10.103.

Prognostic value of multimodality imaging in the contemporary management of cardiac sarcoidosis.

Okafor J, Azzu A, Ahmed R, Ohri S, Wechalekar K, Wells A Open Heart. 2024; 11(2).

PMID: 39462525 PMC: 11529682. DOI: 10.1136/openhrt-2024-002989.

Extracellular Volume and Fibrosis Volume of Left Ventricular Myocardium Assessed by Cardiac Magnetic Resonance in Vaccinated and Unvaccinated Patients with a History of SARS-CoV-2 Infection.

Gac P, Hajdusianek W, Zorawik A, Poreba M, Poreba R Cardiovasc Toxicol. 2024; 24(12):1455-1466.

PMID: 39404974 PMC: 11564387. DOI: 10.1007/s12012-024-09929-3.

References

Lurz P, Luecke C, Eitel I, Fohrenbach F, Frank C, Grothoff M . Comprehensive Cardiac Magnetic Resonance Imaging in Patients With Suspected Myocarditis: The MyoRacer-Trial. J Am Coll Cardiol. 2016; 67(15):1800-1811. DOI: 10.1016/j.jacc.2016.02.013. View

Barone-Rochette G, Pierard S, De Meester de Ravenstein C, Seldrum S, Melchior J, Maes F . Prognostic significance of LGE by CMR in aortic stenosis patients undergoing valve replacement. J Am Coll Cardiol. 2014; 64(2):144-54. DOI: 10.1016/j.jacc.2014.02.612. View

Treibel T, Fridman Y, Bering P, Sayeed A, Maanja M, Frojdh F . Extracellular Volume Associates With Outcomes More Strongly Than Native or Post-Contrast Myocardial T1. JACC Cardiovasc Imaging. 2019; 13(1 Pt 1):44-54. DOI: 10.1016/j.jcmg.2019.03.017. View

Puntmann V, Carr-White G, Jabbour A, Yu C, Gebker R, Kelle S . T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure. JACC Cardiovasc Imaging. 2016; 9(1):40-50. DOI: 10.1016/j.jcmg.2015.12.001. View

Azevedo C, Nigri M, Higuchi M, Pomerantzeff P, Spina G, Sampaio R . Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol. 2010; 56(4):278-87. DOI: 10.1016/j.jacc.2009.12.074. View

Kelle S, Roes S, Klein C, Kokocinski T, de Roos A, Fleck E . Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging. J Am Coll Cardiol. 2009; 54(19):1770-7. DOI: 10.1016/j.jacc.2009.07.027. View

Aquaro G, Perfetti M, Camastra G, Monti L, Dellegrottaglie S, Moro C . Cardiac MR With Late Gadolinium Enhancement in Acute Myocarditis With Preserved Systolic Function: ITAMY Study. J Am Coll Cardiol. 2017; 70(16):1977-1987. DOI: 10.1016/j.jacc.2017.08.044. View

Weng Z, Yao J, Chan R, He J, Yang X, Zhou Y . Prognostic Value of LGE-CMR in HCM: A Meta-Analysis. JACC Cardiovasc Imaging. 2016; 9(12):1392-1402. DOI: 10.1016/j.jcmg.2016.02.031. View

Messroghli D, Moon J, Ferreira V, Grosse-Wortmann L, He T, Kellman P . Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular.... J Cardiovasc Magn Reson. 2017; 19(1):75. PMC: 5633041. DOI: 10.1186/s12968-017-0389-8. View

10.

Becker M, Cornel J, van de Ven P, van Rossum A, Allaart C, Germans T . The Prognostic Value of Late Gadolinium-Enhanced Cardiac Magnetic Resonance Imaging in Nonischemic Dilated Cardiomyopathy: A Review and Meta-Analysis. JACC Cardiovasc Imaging. 2018; 11(9):1274-1284. DOI: 10.1016/j.jcmg.2018.03.006. View

11.

El Aidi H, Adams A, Moons K, den Ruijter H, Mali W, Doevendans P . Cardiac magnetic resonance imaging findings and the risk of cardiovascular events in patients with recent myocardial infarction or suspected or known coronary artery disease: a systematic review of prognostic studies. J Am Coll Cardiol. 2014; 63(11):1031-45. DOI: 10.1016/j.jacc.2013.11.048. View

12.

Hinojar R, Varma N, Child N, Goodman B, Jabbour A, Yu C . T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study. Circ Cardiovasc Imaging. 2015; 8(12). DOI: 10.1161/CIRCIMAGING.115.003285. View

13.

Grani C, Eichhorn C, Biere L, Murthy V, Agarwal V, Kaneko K . Prognostic Value of Cardiac Magnetic Resonance Tissue Characterization in Risk Stratifying Patients With Suspected Myocarditis. J Am Coll Cardiol. 2017; 70(16):1964-1976. PMC: 6506846. DOI: 10.1016/j.jacc.2017.08.050. View

14.

Bulluck H, Hammond-Haley M, Fontana M, Knight D, Sirker A, Herrey A . Quantification of both the area-at-risk and acute myocardial infarct size in ST-segment elevation myocardial infarction using T1-mapping. J Cardiovasc Magn Reson. 2017; 19(1):57. PMC: 5539889. DOI: 10.1186/s12968-017-0370-6. View

15.

Maceira A, Joshi J, Prasad S, Moon J, Perugini E, Harding I . Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005; 111(2):186-93. DOI: 10.1161/01.CIR.0000152819.97857.9D. View

16.

Hamzeh N, Steckman D, Sauer W, Judson M . Pathophysiology and clinical management of cardiac sarcoidosis. Nat Rev Cardiol. 2015; 12(5):278-88. DOI: 10.1038/nrcardio.2015.22. View

17.

Shah Z, Mohammed M, Vuddanda V, Ansari M, Masoomi R, Gupta K . National Trends, Gender, Management, and Outcomes of Patients Hospitalized for Myocarditis. Am J Cardiol. 2019; 124(1):131-136. DOI: 10.1016/j.amjcard.2019.03.036. View

18.

Smedema J, Snoep G, van Kroonenburgh M, van Geuns R, Dassen W, Gorgels A . Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol. 2005; 45(10):1683-90. DOI: 10.1016/j.jacc.2005.01.047. View

19.

Selvanayagam J, Hartshorne T, Billot L, Grover S, Hillis G, Jung W . Cardiovascular magnetic resonance-GUIDEd management of mild to moderate left ventricular systolic dysfunction (CMR GUIDE): Study protocol for a randomized controlled trial. Ann Noninvasive Electrocardiol. 2017; 22(4). PMC: 6931571. DOI: 10.1111/anec.12420. View

20.

Baumgartner H, Falk V, Bax J, De Bonis M, Hamm C, Holm P . 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017; 38(36):2739-2791. DOI: 10.1093/eurheartj/ehx391. View